ADH

[kslifka]

ADH

I've been in this one for a few days and has steadily been moving up on much higher than normal volume.  Friday it crossed the 200dma to the upside.

We have some resistance at .50 and at .68.  I'm thinking volume should carry this one past .50.

Profile:

Adherex Technologies, Inc., a development stage biopharmaceutical company, engages in the discovery and development of novel cancer therapeutics. The company has various products in the clinical stage of development, such as ADH-1, Eniluracil, Sodium Thiosulfate (STS), N-Acetylcysteine (NAC), and Mesna. Its ADH-1 product, which is under phase Ib/II and phase II clinical studies, targets N-cadherin, a protein present on certain tumor cells and established blood vessels that feed solid tumors. In addition, Adherex offers Eniluracil, an oral dihydropyrimidine dehydrogenase inhibitor for oncology indications; STS, which is under phase II clinical studies is a drug that protects against disabling hearing loss associated with platinum-based anticancer agents; NAC, which is under phase I clinical studies is a bone marrow protectant for use in platinum-based chemotherapy; and Mesna, a chemoenhancer that has displayed anti-cancer activity in laboratory studies conducted by investigators. The company�s preclinical pipeline includes back-up peptides and small chemical molecule successors to ADH-1; molecules developed to inhibit the metastatic spread of cancers; and peptides that combine both angiolytic and antiangiogenic properties. It has development and licensing agreements with GlaxoSmithKline, Scynexis, Inc., McGill University, Rutgers, and Oregon Health & Science University. Adherex Technologies also has an agreement with International Childhood Liver Tumour Strategy Group for conducting Phase III trial of sodium thiosulfate, a drug for the prevention of hearing loss in children associated with platinum-based chemotherapies. The company was founded in 1996 and is based in Durham, North Carolina.

[kslifka]

Keeps moving...now above .50.

[pompano]

Applaud the pick, looks real good, especially the volume.

[nica33]

Very bullish action today.  The MACD looks nice.  Lets see if crosses 0.57 with important volume

[calven]

What do you guys think - I might dabble with about a 1-1500 position...

Probably enter in the morning right away - that volume in march and april is amazing!

What do you guys think??? 

[calven]

Heres what I was able to find - basically they bought a "failed" stage 3 cancer drug - they aim to improve it to see different results?

IDK but that volume is crazy!

http://biotech.seekingalpha.com/article/28487
http://biotech.seekingalpha.com/article/24591

[kslifka]

Heres what I was able to find - basically they bought a "failed" stage 3 cancer drug - they aim to improve it to see different results?

IDK but that volume is crazy!

http://biotech.seekingalpha.com/article/28487
http://biotech.seekingalpha.com/article/24591

Calven...with only a $31 million market cap...if they can improve that drug your talking about ADH could fly.

Right now it should move higher Monday with this little G-break-out.

[Ares]

ADH looks like it had it had a bear trap (better seen at the weekly chart at the right screen) followed by a recent bollinger band breakout (on volume, better seen on the daily chart on the left screen).

It looks like it has a momentum entry towards the 5th wave (red line).

Just a heads up on the potential bearish wolfe wave set up (green line)

Potential uptrend channel (yellow line).

Just trying to see the different angle traders may see in ADH.

Current Stockscores http://www.stockscores.com/quickreport.asp?ticker=adh rating is:
Signal = 73
Sentiment = 73

StockScouter rating is 3 http://moneycentral.msn.com/investor/StockRating/srsmain.asp?Symbol=adh

[kslifka]

ADH...looking like it may break higher here.

[Ares]

Just a heads up.
Watch volume for a bull trap.

[kslifka]

ADH...took out .68...next area of resistance near .90.  I love the volume over the past few months.